Dimerized translationally controlled tumor protein increases interleukin-8 expression through MAPK and NF-κB pathways in a human bronchial epithelial cell line

Cell & Bioscience
Heewon Lee, Kyunglim Lee

Abstract

Histamine releasing factor (HRF) is a unique cytokine known to regulate a variety of immune cells in late allergic reactions. In the previous study, we revealed that the biologically active form of HRF is the dimerized translationally controlled tumor protein (dTCTP) for the first time, and confirmed the secretion of IL-8 cytokine by dTCTP in human bronchial epithelial cells. However, the signaling pathway by which dTCTP promotes the secretion of IL-8 is not known. When the cells were stimulated with dTCTP, the canonical NF-κB pathway and ERK, JNK and p38 MAPK become activated. dTCTP promoted transcription of IL-8, which involved NF-κB and AP-1 transcription factors. NF-κB was found to be essential for the transcriptional activation of IL-8, while AP-1 was partially responsible for the transcriptional activation by dTCTP. p38 MAPK was found to be involved in post-transcriptional regulation of dTCTP by stabilizing IL-8 mRNA. This study demonstrated that dTCTP induces IL-8 secretion in BEAS-2B cells through transcriptional and post-transcriptional regulation of MAPK and NF-κB pathways. This study provides insight into the mechanism by which dTCTP induces inflammation.

References

Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K FuruichiC Isersky
Aug 4, 1995·Science·S M MacDonaldL M Lichtenstein
Jul 3, 1998·American Journal of Respiratory Cell and Molecular Biology·A M CampbellJ Bousquet
Apr 13, 1999·The Journal of Allergy and Clinical Immunology·F WantkeS M MacDonald
May 18, 1999·The Journal of Allergy and Clinical Immunology·R Bheekha-EscuraS M MacDonald
Jul 1, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·K A Roebuck
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H S KangI Choi
Jul 2, 2002·American Journal of Respiratory Cell and Molecular Biology·Séverine Oudin, Jérôme Pugin
Sep 2, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kazuo YonedaSaburo Sone
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jiro KitauraToshiaki Kawakami
Dec 23, 2003·The International Journal of Biochemistry & Cell Biology·Ulrich-Axel Bommer, Bernd-Joachim Thiele
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jiro KitauraToshiaki Kawakami
Feb 16, 2006·The Journal of Infectious Diseases·Jamison GreenStephen J Polyak
Aug 22, 2007·American Journal of Respiratory Cell and Molecular Biology·Neeraj VijPamela L Zeitlin
May 20, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kathryn ChmuraEdward D Chan
Mar 9, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Miyoung KimKyunglim Lee
Oct 28, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Valentino BezzerriGiulio Cabrini
Dec 3, 2011·The Journal of Clinical Investigation·Jun-chi KashiwakuraToshiaki Kawakami

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
transfection
scraping
PCR
Assay
fluorescence microscopy
LightShift
nuclear translocation
ELISA

Software Mentioned

GraphPad
GraphPad Prisms

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.